1,876,671 Shares in Healthcare Realty Trust Incorporated $HR Acquired by Jupiter Asset Management Ltd.

Jupiter Asset Management Ltd. bought a new position in shares of Healthcare Realty Trust Incorporated (NYSE:HR) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,876,671 shares of the real estate investment trust’s stock, valued at approximately $31,810,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HR. PGGM Investments bought a new stake in Healthcare Realty Trust during the fourth quarter worth approximately $113,389,000. Invesco Ltd. grew its position in Healthcare Realty Trust by 233.8% in the third quarter. Invesco Ltd. now owns 7,700,760 shares of the real estate investment trust’s stock worth $138,845,000 after buying an additional 5,393,651 shares during the last quarter. Russell Investments Group Ltd. grew its position in Healthcare Realty Trust by 68.7% in the third quarter. Russell Investments Group Ltd. now owns 4,392,815 shares of the real estate investment trust’s stock worth $79,201,000 after buying an additional 1,789,111 shares during the last quarter. Rush Island Management LP grew its position in Healthcare Realty Trust by 13.8% in the second quarter. Rush Island Management LP now owns 14,260,152 shares of the real estate investment trust’s stock worth $226,166,000 after buying an additional 1,728,491 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Healthcare Realty Trust by 418.3% in the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,947,274 shares of the real estate investment trust’s stock worth $35,109,000 after buying an additional 1,571,583 shares during the last quarter.

Healthcare Realty Trust Stock Performance

NYSE HR opened at $20.10 on Friday. Healthcare Realty Trust Incorporated has a twelve month low of $14.09 and a twelve month high of $20.61. The stock has a market cap of $6.97 billion, a price-to-earnings ratio of -34.66 and a beta of 0.97. The firm’s 50 day moving average price is $18.68 and its two-hundred day moving average price is $17.95.

Healthcare Realty Trust (NYSE:HR) last posted its quarterly earnings data on Thursday, April 30th. The real estate investment trust reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.02. Healthcare Realty Trust had a negative net margin of 17.34% and a negative return on equity of 4.29%. The firm had revenue of $275.28 million for the quarter, compared to analysts’ expectations of $283.01 million. During the same period in the previous year, the company posted $0.39 EPS. The company’s quarterly revenue was down 7.7% compared to the same quarter last year. Healthcare Realty Trust has set its FY 2026 guidance at 1.590-1.65 EPS. On average, research analysts forecast that Healthcare Realty Trust Incorporated will post 1.61 EPS for the current fiscal year.

Healthcare Realty Trust Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, May 22nd. Stockholders of record on Monday, May 11th were issued a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a dividend yield of 4.8%. The ex-dividend date was Monday, May 11th. Healthcare Realty Trust’s payout ratio is currently -165.52%.

Insider Activity at Healthcare Realty Trust

In related news, Director Thomas N. Bohjalian purchased 10,000 shares of the stock in a transaction dated Friday, March 6th. The shares were acquired at an average cost of $18.09 per share, for a total transaction of $180,900.00. Following the acquisition, the director directly owned 85,520 shares in the company, valued at approximately $1,547,056.80. The trade was a 13.24% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.56% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have issued reports on HR. Scotiabank lifted their price target on shares of Healthcare Realty Trust from $20.00 to $22.00 and gave the stock an “outperform” rating in a research report on Friday, May 8th. Royal Bank Of Canada lifted their price target on shares of Healthcare Realty Trust from $19.00 to $21.00 and gave the stock a “sector perform” rating in a research report on Thursday, May 14th. Citigroup lifted their price target on shares of Healthcare Realty Trust from $19.00 to $21.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. UBS Group lifted their price target on shares of Healthcare Realty Trust from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, May 13th. Finally, Weiss Ratings lowered shares of Healthcare Realty Trust from a “hold (c)” rating to a “sell (d+)” rating in a research report on Monday, May 4th. Four equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Healthcare Realty Trust presently has an average rating of “Hold” and a consensus price target of $20.25.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.

The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.